Wilding IR - Search Results

1

Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects.

Coupe AJ, Davis SS, Wilding IR. Coupe AJ, et al. Among authors: wilding ir. Pharm Res. 1991 Mar;8(3):360-4. doi: 10.1023/a:1015849700421. Pharm Res. 1991. PMID: 2052525

2

Gamma scintigraphy in the evaluation of pharmaceutical dosage forms.

Davis SS, Hardy JG, Newman SP, Wilding IR. Davis SS, et al. Among authors: wilding ir. Eur J Nucl Med. 1992;19(11):971-86. doi: 10.1007/BF00175865. Eur J Nucl Med. 1992. PMID: 1425786 Review.

3

In vivo evaluation of enteric-coated naproxen tablets using gamma scintigraphy.

Wilding IR, Hardy JG, Sparrow RA, Davis SS, Daly PB, English JR. Wilding IR, et al. Pharm Res. 1992 Nov;9(11):1436-41. doi: 10.1023/a:1015858829187. Pharm Res. 1992. PMID: 1475230 Clinical Trial.

4

New developments in sustained-release antihypertensive therapy: formulation and pharmacokinetic considerations.

Devane JG, Mulligan S, Kavanagh M, Davis SS, Sparrow RA, Wilding IR. Devane JG, et al. Among authors: wilding ir. Am J Cardiol. 1992 Apr 30;69(13):23E-27E. doi: 10.1016/0002-9149(92)90014-p. Am J Cardiol. 1992. PMID: 1575173

5

Gastrointestinal transit and systemic absorption of captopril from a pulsed-release formulation.

Wilding IR, Davis SS, Bakhshaee M, Stevens HN, Sparrow RA, Brennan J. Wilding IR, et al. Pharm Res. 1992 May;9(5):654-7. doi: 10.1023/a:1015806211556. Pharm Res. 1992. PMID: 1608898 Clinical Trial.

6

Correlation of the gastric emptying of nondisintegrating tablets with gastrointestinal motility.

Coupe AJ, Davis SS, Evans DF, Wilding IR. Coupe AJ, et al. Among authors: wilding ir. Pharm Res. 1991 Oct;8(10):1281-5. doi: 10.1023/a:1015855829864. Pharm Res. 1991. PMID: 1796047

7

Characterisation of the in vivo behaviour of a controlled-release formulation of levodopa (Sinemet CR).

Wilding IR, Hardy JG, Davis SS, Melia CD, Evans DF, Short AH, Sparrow RA, Yeh KC. Wilding IR, et al. Clin Neuropharmacol. 1991 Aug;14(4):305-21. doi: 10.1097/00002826-199108000-00003. Clin Neuropharmacol. 1991. PMID: 1913698 Clinical Trial.

8

A simple and rapid method for the quantification of Eudragit RS100 and RL100 poly(methacrylates) in sustained-release dosage forms.

Melia CD, Hansraj BR, Khan KA, Wilding IR. Melia CD, et al. Among authors: wilding ir. Pharm Res. 1991 Jul;8(7):899-902. doi: 10.1023/a:1015859713992. Pharm Res. 1991. PMID: 1924142

9

Relationship between systemic drug absorption and gastrointestinal transit after the simultaneous oral administration of carbamazepine as a controlled-release system and as a suspension of 15N-labelled drug to healthy volunteers.

Wilding IR, Davis SS, Hardy JG, Robertson CS, John VA, Powell ML, Leal M, Lloyd P, Walker SM. Wilding IR, et al. Br J Clin Pharmacol. 1991 Nov;32(5):573-9. doi: 10.1111/j.1365-2125.1991.tb03954.x. Br J Clin Pharmacol. 1991. PMID: 1954073 Free PMC article.

10

Gastrointestinal transit of Sinemet CR in healthy volunteers.

Wilding IR, Davis SS, Melia CD, Hardy JG, Evans DF, Short AH, Sparrow RA. Wilding IR, et al. Neurology. 1989 Nov;39(11 Suppl 2):53-8. Neurology. 1989. PMID: 2685651 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters